Details for Patent: 11,278,601
✉ Email this page to a colleague
Which drugs does patent 11,278,601 protect, and when does it expire?
Patent 11,278,601 protects OPFOLDA and is included in one NDA.
This patent has fifty-one patent family members in thirty countries.
Summary for Patent: 11,278,601
Title: | Augmented acid alpha-glucosidase for the treatment of Pompe disease |
Abstract: | A method for treating Pompe disease including administration of recombinant human acid α-glucosidase having optimal glycosylation with mannose-6-phosphate residues in combination with an amount of miglustat effective to maximize tissue uptake of recombinant human acid α-glucosidase while minimizing inhibition of the enzymatic activity of the recombinant human acid α-glucosidase is provided. |
Inventor(s): | Do Hung V., Khanna Richie, Gotschall Russell |
Assignee: | Amicus Therapeutics, Inc. |
Application Number: | US17061691 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,278,601
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amicus Therap Us | OPFOLDA | miglustat | CAPSULE;ORAL | 215211-001 | Sep 28, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | THE TREATMENT OF POMPE PATIENTS | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,278,601
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 107277 | ⤷ Sign Up | |||
Australia | 2016381832 | ⤷ Sign Up | |||
Australia | 2024200071 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |